Advances in Study on Biological Agents in Treatment of Moderate-to-severe Ulcerative Colitis

Author: Xinwen XU ¹ ; Qunyan ZHOU ¹ ; Zhongxia CHEN ¹ ; Yue WU ¹ ; Qiuyu CHEN ¹ ; Jing SUN ¹ ; Qiang ZHAN ¹
Author Information

1. Department of Gastroenterology, The Affiliated Wuxi People's Hospital, Nanjing Medical University
Publication Type:Journal Article
Keywords: Biological Agents; Colitis, Ulcerative; Drug Monitoring; Neoplasms; Therapy
From:Chinese Journal of Gastroenterology 2021;26(6):363-367
CountryChina
Language:Chinese
Abstract: Ulcerative colitis (UC) is a non-specific, chronic and relapsing intestinal inflammatory disease with unknown etiology. Biological agents had been used to treat UC, and efficacy was superior to traditional therapeutic drugs, however, many problems followed. This article reviewed the application of biological agents in the treatment of moderate-to-severe UC, therapeutic drug monitoring, special conditions occurred during the use of biological agents and their management.